7Sigurs N, Bjamason R, Sigurbergason F, et al. Respiratory syneytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7 [J]. Am J Respir Crit Cure Med, 2000, 161(5): 1501-1507. [3] Bisgaard H, Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis [J]. Am J Respir Crit Care Med, 2003. 167(3): 379-383.
8Bisgaard H, Study Group on Montelukast and Respiratory Syncytial Virus. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis [J]. Am J Respir Crit Care Med, 2003, 167(3): 379-383.
9Keams GL, Lu S, Maganti L, et al. Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitis [ J ]. J Clin Pharmacol, 2008, 48 (4) : 510-511.
